Please provide your email address to receive an email when new articles are posted on . Vyznova received regulatory approval in Japan for the treatment of bullous keratopathy. Injectable endothelial ...
Please provide your email address to receive an email when new articles are posted on . According to Yeu, one of the first surgeons to perform the procedure, patients in El Salvador had a level of ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Corneal transplantation using donor tissue is currently the primary treatment for corneal endothelial insufficiency. Despite the potential for vision restoration through corneal transplantation, there ...
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., ...
Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal ...
Iridocorneal Endothelial Syndrome is a rare eye diseases that causes swelling inside the cornea and changes in the iris (the colored part of your eye). Because Iridocorneal Endothelial Syndrome causes ...
CLEVELAND - A new predictor of cornea transplant success has been identified by the Cornea Donor Study (CDS) Investigator Group. New analysis of data from the 2008 Specular Microscopy Ancillary Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback